PLx Pharma up on strong aspirin sales, smaller-than-expected Q3 loss

PLx Pharma Winddown

12/11/2021 13:21

** Shares of drugmaker  PLXP.O  rise 9.3% to $14.25
premarket
    ** Company reports Q3 revenue of $6.6 mln, beating Refinitiv
IBES estimates of $4.1 mln, boosted by strong demand for its
aspirin capsule Vazalore  urn:newsml:reuters.com:*:nGNX74N7J6
    ** The U.S. FDA had earlier this year approved two doses of
the drug; PLXP says Q3 net sales were led by lower dose
    ** Reports adjusted net loss of 37 cents/shr in the qtr vs
estimates of 46 cents/shr
    ** Stock had more than doubled in value YTD, up to the last
close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))